RecruitingNot ApplicableNCT04744935
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
Sponsor
Christopher Zachary
Enrollment
40 participants
Start Date
Jan 13, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Optical coherence tomography guided laser treatment of basal cell carcinoma
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Plain Language Summary
Simplified for easier understanding
This study tests whether using optical coherence tomography (OCT) — a type of detailed skin imaging — to guide laser treatment of basal cell carcinoma (a common skin cancer) improves treatment outcomes by helping the doctor see exactly how far the cancer extends.
**You may be eligible if...**
- You are 18 or older
- You have a basal cell carcinoma (BCC) that has already been confirmed by a prior biopsy
- You are scheduled for treatment of this BCC
- You or your legal guardian can understand and follow study instructions
**You may NOT be eligible if...**
- Your BCC is large (greater than 2.5 cm) or requires surgical excision
- You have a BCC in a high-risk location (like the nose, eyelids, or ears) where laser therapy is not appropriate
- You have a known allergy to the treatment materials used
- You are immunocompromised
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICE1064 nm long-pulse Nd:YAG laser
BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04744935
Related Trials
Raman Spectroscopy and Skin Cancer
NCT063849241 location
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
NCT035218301 location
Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
NCT059296643 locations
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
NCT0434943628 locations
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
NCT071822401 location